Objective: To analyze whether the use of an intermittent (IAD) versus continuous (CAD) androgen deprivation therapy for the treatment of biochemical progression after primary treatments (radical prostatectomy and radiation therapy) in hormone sensitive non-metastatic prostate cancer can influence the development of non-metastatic castration resistant prostate cancer (CRPC-M0) .
Intermittent versus continuous androgen deprivation therapy for biochemical progression after primary therapy in hormone-sensitive nonmetastatic prostate cancer. Comparative analysis in terms of CRPC-M0 progression / Salciccia, Stefano; Frisenda, Marco; Tufano, Antonio; Pierro, Giovanni Di; Bevilacqua, Giulio; Rosati, Davide; Gobbi, Luca; Basile, Greta; Moriconi, Martina; Mariotti, Gianna; Forte, Flavio; Carbone, Antonio; Pastore, Antonio; Cattarino, Susanna; Sciarra, Alessandro; Gentilucci, Alessandro. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - 22:2(2024), pp. 74-83. [10.1016/j.clgc.2023.08.008]
Intermittent versus continuous androgen deprivation therapy for biochemical progression after primary therapy in hormone-sensitive nonmetastatic prostate cancer. Comparative analysis in terms of CRPC-M0 progression
Salciccia, Stefano;Frisenda, Marco;Tufano, Antonio;Pierro, Giovanni Di;Bevilacqua, Giulio;Gobbi, Luca;Basile, Greta;Moriconi, Martina;Forte, Flavio;Pastore, Antonio;Cattarino, Susanna;Sciarra, Alessandro
;Gentilucci, Alessandro
2024
Abstract
Objective: To analyze whether the use of an intermittent (IAD) versus continuous (CAD) androgen deprivation therapy for the treatment of biochemical progression after primary treatments (radical prostatectomy and radiation therapy) in hormone sensitive non-metastatic prostate cancer can influence the development of non-metastatic castration resistant prostate cancer (CRPC-M0) .File | Dimensione | Formato | |
---|---|---|---|
Salciccia_Intermittent_2024.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
660.29 kB
Formato
Adobe PDF
|
660.29 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.